Literature DB >> 9294322

[Hypercoagulable state in Duchenne muscular dystrophy].

Y Saito1, T Komiya, M Kawai.   

Abstract

Pulmonary and cerebral infarctions have come to be noticed as life-threatening complications of Duchenne muscular dystrophy (DMD). In order to elucidate the underlying mechanism of hypercoagulable state, was studied following markers of coagulation and fiblinolysis in 69 DMD and 50 control patients showing no signs of thrombosis: prothrombin time, activated partial thrombin time, thrombotest, fibrinogen, fibrinogen degradation product, thrombin-antithrombin III complex (TAT), alpha 2-plasmin inhibitor plasmin complex (PIC), D-dimer, protein C activity, protein S, antithrombin III, XII factor, thrombomodulin and plasminogen activity. 66 out of 69 patients (96%) showed abnormal results in more than one of these studies, among which abnormally low thrombotest (78%), high TAT (61%) and high PIC (40.3%), were very frequently observed. The results were not correlated to the age, the activity of daily living and the respiratory of cardiac functions. Significantly smaller number of the control patients suffering from other neuromuscular diseases showed abnormal results, while the ambulatory DMD patients not infrequently showed hypercoagulable state. These results strongly suggest that unknown inherent factor(s) as well as inevitable immobilization and cardiac dysfunction play(s) an important role in the development of hypercoagulable state in this intractable disorder.

Entities:  

Mesh:

Year:  1997        PMID: 9294322

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN: 0009-918X


  3 in total

1.  Echocardiographic diagnosis, management and monitoring of pulmonary embolism with right heart thrombus in a patient with myotonic dystrophy: a case report.

Authors:  Bernd Hewing; Leyli Ghaeni; Henryk Dreger; Eva M Fallenberg; Alexander Panda; Gert Baumann; Adrian C Borges
Journal:  Cardiovasc Ultrasound       Date:  2010-05-16       Impact factor: 2.062

2.  Myotonic dystrophy type 1 and pulmonary embolism: successful thrombus resolution with dabigatran etexilate therapy.

Authors:  Emanuele Gallinoro; Andrea Antonio Papa; Anna Rago; Simona Sperlongano; Antonio Cassese; Nadia Della Cioppa; Maria Cristina Giada Magliocca; Giovanni Cimmino; Paolo Golino
Journal:  Acta Myol       Date:  2018-09-01

3.  Pulmonary thromboembolism in a patient with myotonic dystrophy type 1.

Authors:  Joong-Yang Cho; So-Young Seo; Yong-Jin Cho; Keun-Sik Hong; Hee Kyung Park; Ju Hyun Lee; Sung-Soon Lee
Journal:  Ann Indian Acad Neurol       Date:  2012-10       Impact factor: 1.383

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.